Fig. 8From: LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinomaCorrelation between LPCAT1 expression and drug sensitivity in HCC, including 5-Fluorouracil (A), Gemcitabine (B), Mitomycin C (C), Irinotecan (D), Sorafenib (E), and Cabozantinib (F). *p < 0.05; **p < 0.01; ***p < 0.001Back to article page